Oncology & Immunology

Expert reports about Oncology & Immunology


THE SAFETY OF ADALIMUMAB (HUMIRA) DURING PREGNANCY OR BREASTFEEDING

 

THIS MEDICATION CAN CAUSE HARM TO YOUR BABY:

Adalimumab has a low risk with use during pregnancy, but it is important to speak with your doctor if you are on this medication and become pregnant.


TO READ THE FULL REPORT

Join Pregistry to access the information you need at no cost to you

Join Pregistry